Summary
Further to the presentation given in the April 2024 CMAG meeting on allergic reactions caused by drug content, this page has been set up to collect questions and responses from National Release Centers. Please add your comments and questions to this page.
Bruce Goldberg Farzaneh Ashrafi
Country response
| Country | Date | Response |
|---|
| UK | | - Which SNOMED Member(s) are requesting these changes?
- What specific recording use cases will they meet?
- What evidence is there that the replication of the same 1000-or-so concepts beneath ‘allergy to drug’ will necessarily meet the needs of a requirement to record ‘allergic reaction to drug’?
- How do the changes proposed align with the representation of allergic reactions (in contrast to allergic propensity/allergy) already recommended to SNOMED CT users in the (relatively recently-published) SI Allergy Implementation Guide?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Member countries without a CMAG rep |
|
|
Final outcome:
Date: